27141 Patient-reported Psoriasis Symptoms Stratified by Sex and Level of Skin Clearance in Clinical Trials of Brodalumab

Background: The psoriasis symptom inventory (PSI) is a validated tool measuring patient-reported psoriasis signs and symptoms, with higher scores indicating increased severity. This post hoc analysis examines PSI response rates and scores stratified by sex and skin clearance levels in clinical trials of brodalumab, an interleukin-17 receptor A antagonist efficacious for treatment of moderate-to-severe psoriasis.